Trimel Pharmaceuticals Corp.  

(Public, TSE:TRL)   Watch this stock  
Find more results for tse:trl
0.620
-0.020 (-3.12%)
Jul 22 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.62 - 0.63
52 week 0.34 - 0.93
Open 0.62
Vol / Avg. 189,255.00/219,657.00
Mkt cap 104.40M
P/E     -
Div/yield     -
EPS -0.19
Shares 163.13M
Beta -0.46
Inst. own     -
Jul 28, 2014
Q2 2014 Trimel Pharmaceuticals Corp Earnings Release (Estimated) Add to calendar
Jun 24, 2014
Trimel Pharmaceuticals Corp at JMP Securities Healthcare Conference
Jun 18, 2014
Trimel Pharmaceuticals Corp at Bloom Burton & Co Healthcare Investor Conference
Jun 12, 2014
Trimel Pharmaceuticals Corp Conference Call to Provide In-Depth Review of the TefinaT Phase II Study Results
Jun 12, 2014
Trimel Pharmaceuticals Corp Annual Shareholders Meeting
May 9, 2014
Q1 2014 Trimel Pharmaceuticals Corp Earnings Conference Call
May 8, 2014
Q1 2014 Trimel Pharmaceuticals Corp Earnings Release